Akari Therapeutics PLC (NAS:AKTX)
$ 1.12 -0.02 (-1.75%) Market Cap: 27.73 Mil Enterprise Value: 26.48 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Akari Therapeutics PLC To Host a Virtual Key Opinion Leader Event Transcript

Oct 19, 2023 / 03:30PM GMT
Release Date Price: $3.55 (+2.90%)
Operator

Good afternoon and welcome to the Akari Therapeutics KOL event. (Operator Instructions) As a reminder, this call is being recorded and a replay will be made available on the Akari website following the conclusion of the event.

I'd now like to turn the call over to Rachelle Jacques, President and Chief Executive Officer of Akari Therapeutics. Please go ahead, Rachelle.

Rachelle Jacques
Akari Therapeutics, plc - President & CEO

Thanks, Tara, and welcome, everybody. As Tara mentioned, I'm Rachelle Jacques, CEO of Akari Therapeutics and really pleased to have you all here today. Thank you for joining our Key Opinion Leader event, and we're going to focus today on geographic atrophy and the potential of long-acting PASylated-nomacopan to address significant needs in the area.

So today's webinar is going to be featuring Dr. Elias Reichel. Of course, we are going to be making forward-looking statements. So just a take note there, please.

And let me now introduce Dr. Reichel, who is going to give us a brief overview of geographic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot